MedPath
PPB Approval

EVRYSDI POWDER FOR ORAL SOLUTION 0.75MG/ML

HK-67230

Prescription only Medicines

October 7, 2021

Company Information

Company Details

22/F, CTF LIFE TOWER, 18, SHEUNG YUET ROAD, KOWLOON BAY, KOWLOON

Active Ingredients

risdiplam

Drug Monographs

Risdiplam

利司扑兰

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EVRYSDI POWDER FOR ORAL SOLUTION 0.75MG/ML - PPB 批准文号 | MedPath